There have been exponential gains in immuno-oncology in recent times through the development of immune checkpoint inhibitors. Already approved by the U.S. Food
Intravesical Bacillus Calmette-Guérin(BCG) has long been the gold standard treatment of nonmuscle invasive bladder cancer.Recently, there has been an emergence